
Study finds 70% of antibiotic FDC drugs sold in India were unapproved or banned
Don't Miss
A selection of the best news reports, analysis and opinions published by ThePrint this week.
The Print, 19 November, 2023 : 70% of antibiotic fixed-dose combination drugs sold in India unapproved or banned, finds study
Govt’s moves to curb irrational fixed-dose combinations may have been insufficient & lack enforcement, say researchers. Study published in Journal of Pharmaceutical Policy and Practice, reports Sumi Sukanya Dutta.
Rabinder Singh spy scandal exposed R&AW’s ugly sides. But India hasn’t learned from its mistakes
Vishal Bhardwaj’s Khufiya touches on the penetration of R&AW. The reel-world denouement, though, was quite different from the real-world ending, reports Praveen Swami.
How much debt is too much debt? Curious case of Pakistan’s $69 billion Chinese debt trap
Data shows China has committed $68.91 bn in long-term loans to Pakistan & that Islamabad secured at least one emergency rescue loan from Beijing each year from 2012 till 2021, reports Keshav Padmanabhan.
Biden-Xi closeness clearly shows one thing—The goal to undermine regional powers like India
India as a strong votary of multilateralism against competition between two hegemonic powers should be concerned, writes Seshadri Chari.
Stop taking pride in Indian-origin politicians abroad. Many are phonies & racists
Many Indian politicians abroad are unscrupulous apologists for racism and empire. Look at Suella Braverman and Vivek Ramaswamy, writes Vir Sanghvi.
2024 will spring a major surprise in Tamil Nadu. Three new faces are going to emerge
Eight major regional satraps dominate the peninsula. An in-depth state-wise analysis of politics in South India may hold some merit to gauge what can unfold in 2024, writes R. Rajagopalan.
India is seeing a Blue Revolution like never before. Fast bowlers, fitness & ‘the system’
At the point you are reading this, Indian team holds #1 spot in ICC rankings in all 3 formats of the game. The biggest reason behind this success is the rise of a true meritocracy, writes Shekhar Gupta in this week’s ‘National Interest’.
0 Response to "Study finds 70% of antibiotic FDC drugs sold in India were unapproved or banned"
Post a Comment
Disclaimer Note:
The views expressed in the articles published here are solely those of the author and do not necessarily reflect the official policy, position, or perspective of Kalimpong News or KalimNews. Kalimpong News and KalimNews disclaim all liability for the published or posted articles, news, and information and assume no responsibility for the accuracy or validity of the content.
Kalimpong News is a non-profit online news platform managed by KalimNews and operated under the Kalimpong Press Club.
Comment Policy:
We encourage respectful and constructive discussions. Please ensure decency while commenting and register with your email ID to participate.
Note: only a member of this blog may post a comment.